Chronic Myeloid Leukemia Clinical Trials

A listing of Chronic Myeloid Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Colorado

Denver Colorado 80218

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Florida

Miami Florida 33136

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Georgia

Atlanta Georgia 30322

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Atlanta Georgia

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Indiana

Indianapolis Indiana 46237

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Indianapolis Indiana 46237

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Indianapolis Indiana 46202

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Indianapolis Indiana

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Maryland

Baltimore Maryland 21287

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Massachusetts

Boston Massachusetts 02215

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia

Michigan

Ann Arbor Michigan 48109-5000

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Missouri

Creve Coeur Missouri 63141-6337

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63129

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

St. Louis Missouri 63110

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

New York

New York New York 10065

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

New York New York 10021

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

New York New York 10065

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Texas

Dallas Texas 75390

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Houston Texas 77030

A clinical research study of Dasatinib and Decitabine for the treatment of Leukemia

Houston Texas 77030

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Houston Texas 77030

A clinical trial to evaluate treatments using Eltrombopag for patients with Leukemia

Houston Texas

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

View More ▼

Houston Texas 77030

Patients are needed to participate in a clinical research study of Ruxolitinib and TKI to evaluate Leukemia

San Antonio Texas 78229

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

San Antonio Texas 78217

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Virginia

Fairfax Virginia 22031

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Norfolk Virginia 23502

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Washington

Seattle Washington 98109

A clinical trial seeking patients for a research study for the treatment of Previously Treated PH + CML

Vancouver Washington 98684

A Phase 1 clinical study for patients with Advanced, Refractory Hematologic Malignancy

Wisconsin

Milwaukee Wisconsin 53226

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Germany

UPDATED

Aachen 52074

Patients are needed to participate in a clinical research study of Imatinib and Nilotinib to evaluate Patients With CML in First Chronic Phase and Confirmed MMR Receiving Imatinib at the Standard Dose of 400 mg Daily for at Least Two Years.

UPDATED

Aschaffenburg 63739

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Augsburg 86150

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Augsburg 86156

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Augsburg 86150

Patients are needed to participate in a clinical research study of Imatinib and Nilotinib to evaluate Patients With CML in First Chronic Phase and Confirmed MMR Receiving Imatinib at the Standard Dose of 400 mg Daily for at Least Two Years.

View More ▼

UPDATED

Bad Saarow 15526

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Bayreuth 95445

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Berlin 13353

A Phase 1/Phase 2 clinical study for patients with Chronic Myeloid Leukemia (CML)

UPDATED

Berlin 13581

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Berlin 13353

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Berlin 14195

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Berlin 13357

Patients are needed to participate in a clinical research study evaluating Nilotinib for the treatment of Chronic Myeloid Leukemia (CML)

UPDATED

Bonn 53105

Patients are needed to participate in a clinical research study of Imatinib and Nilotinib to evaluate Patients With CML in First Chronic Phase and Confirmed MMR Receiving Imatinib at the Standard Dose of 400 mg Daily for at Least Two Years.